CD8A and neoplasm: Although the anti-tumor immunity is primarily executed by CD4 T cells, CD8 T cells, and natural killer (NK) T cells, B cells are also seen within the TME of some tumors, and patients often develop IgG that is specifically reactive with tumor antigens [65,66].